Notice: Policy on Bioequivalence Standards for Highly Variable Drug Products
Notice: Policy on Bioequivalence Standards for Highly Variable Drug Products is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2021-06-01. On CanQuery you can follow the original downloads. Files are available in English and French.
This Notice serves to inform sponsors of drug submissions pursuant to Division C.08 of the Food and Drug Regulations (that is [i.e.], new drug and abbreviated new drug submissions) of changes in Health Canada's comparative bioavailability requirements for drug products which exhibit large pharmacokinetic within-subject variation in extent of absorption, as measured by area under the concentration versus time curve (AUC).
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-06-01
Data overview
- Formats
- HTML
- File languages
- English, French